Great Novel Therapeutics Biotech & Medicals Corp. (7427) Stock Price & Analysis

7427 Stock Chart & Stats

NT$58.20-NT$1.60(-2.68%)

At close: Nov 06 1:54 AM EST

Day’s Range: TWD 54.30 - TWD 59.70
52-Week Range: TWD 28.40 - TWD 82.80
Previous Close: TWD 59.80
Volume: N/A
Average Volume (3M): 245.77K
Market Cap: TWD 3.07B
Enterprise Value: N/A
Total Cash (Recent Filing): TWD 698.97M
Total Debt (Recent Filing): TWD 6.43M
Price to Earnings (P/E): ―
Beta: 0.21
Next Earnings: N/A
EPS Estimate: N/A
Next Dividend Ex-Date: N/A
Dividend Yield: N/A

7427 FAQ

What was Great Novel Therapeutics Biotech & Medicals Corp.’s price range in the past 12 months?

Great Novel Therapeutics Biotech & Medicals Corp. lowest stock price was TWD 28.40 and its highest was TWD 82.80 in the past 12 months.

What is Great Novel Therapeutics Biotech & Medicals Corp.’s market cap?

Great Novel Therapeutics Biotech & Medicals Corp.’s market cap is TWD 3.07B.

When is Great Novel Therapeutics Biotech & Medicals Corp.’s upcoming earnings report date?

The company’s upcoming earnings report date is not yet available.

Is Great Novel Therapeutics Biotech & Medicals Corp. overvalued?

Not enough analysts have published a price target to calculate whether the price is overvalued.

Does Great Novel Therapeutics Biotech & Medicals Corp. pay dividends?

Great Novel Therapeutics Biotech & Medicals Corp. does not currently pay dividends.

What is Great Novel Therapeutics Biotech & Medicals Corp.’s EPS estimate?

Great Novel Therapeutics Biotech & Medicals Corp.’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Great Novel Therapeutics Biotech & Medicals Corp. have?

Great Novel Therapeutics Biotech & Medicals Corp. has 54,026,234 shares outstanding.

Which hedge fund is a major shareholder of Great Novel Therapeutics Biotech & Medicals Corp.?

Currently, no hedge funds are holding shares in TW:7427

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description